logo
logo

Symap Medical Ltd. Closes Largest Financing Round In Renal Denervation Field

Dec 07, 2021•almost 4 years ago
Suzhou

Description

SyMap Medical (SyMap) announced its latest financing round of nearly $100 million led by Primavera Capital and VMS Group, with the participation of existing investors Simiao Equity Investment and Sequoia Capital China. CEC Capital served as the exclusive financial advisor for this transaction.

Company Information

Company

Sy Map Medical Ltd

Location

Suzhou, Jiangsu, China

About

Guided by the principle of "passion for innovation and value creation," the firm has invested in multiple innovative companies including Venus MedTech, CLOUDR and REJOIN.